Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-16954Germany
BA.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.1.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.75.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.66NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.3.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.49.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.3.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.3.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GE.1.2.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.58.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.8.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDD.1.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDNNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.20NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DV.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4.1.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-11063.7Germany
BN.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.1.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.75NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.5.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.36NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BE.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.23NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.44NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.3.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LT.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.8.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LV.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.54.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.30.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1.1.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
MN.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.63NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LE.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LH.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used